Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: what...

Area of Science:

• Cardiology
• Interventional Cardiology
• Public Health

Background:

• Primary percutaneous coronary intervention (PCI) is the gold standard treatment for ST-segment elevation myocardial infarction (STEMI).
• Randomized controlled trials demonstrate superior outcomes for primary PCI compared to thrombolytic therapy.
• Challenges exist in implementing primary PCI universally outside clinical trial settings.

Purpose of the Study:

• To identify obstacles to widespread primary PCI adoption for STEMI.
• To propose strategies for increasing timely access to primary PCI.
• To advocate for universal availability of primary PCI for STEMI patients.

Main Methods:

• Review of data from randomized, controlled trials on primary PCI for STEMI.
• Identification of anticipated barriers to primary PCI implementation.
• Proposal of strategies to overcome access and expertise limitations.

Main Results:

• Primary PCI significantly reduces mortality and major adverse events like stroke and reinfarction in STEMI patients.
• Key obstacles include limited availability, technical expertise, unstudied patient subgroups, and newer pharmacologic comparisons.
• Proposed solutions involve performing PCI in qualified community hospitals, patient transfer systems, and direct ambulance diversion to PCI centers.

Conclusions:

• Primary PCI offers superior clinical outcomes for STEMI.
• Systemic changes are needed to ensure all STEMI patients can access this life-saving intervention.
• Implementing proposed strategies can enhance primary PCI accessibility and improve patient care.